Results 181 to 190 of about 547,277 (291)
Baseline amyloid burden and global cognitive change during a home-based tDCS protocol in late-life depression: an exploratory single-arm study. [PDF]
Li Y, Park J, Park JY, Kim WJ.
europepmc +1 more source
A Diagnostic Pitfall in the Era of Amyloid-Targeting Therapy: Creutzfeldt-Jakob Disease Masquerading as Biologically Defined Alzheimer's Disease. [PDF]
Manabe Y.
europepmc +1 more source
Objective To characterize magnetic resonance imaging (MRI)‐based glymphatic surrogates in Huntington's disease (HD) using MRI measures of perivascular diffusivity and structural perivascular alterations across multiple large cohorts. Methods We analyzed 2,731 MRI sessions from 880 participants across 3 large retrospective HD cohorts.
Alexia Solomon +5 more
wiley +1 more source
The molecular consequences of specific lysine modifications in Alzheimer´s disease remain insufficiently resolved in the context of full‐length protein. Here we integrate protein semisynthesis, segmental isotope labelling, and high‐resolution NMR spectroscopy to achieve residue‐resolved interrogation of site‐specific acetylation and carboxymethylation.
Dominik P. Vogl +4 more
wiley +2 more sources
Trends in diagnosis of amyloid kidney disease in people who inject drugs (PWID). [PDF]
Narayanan S +3 more
europepmc +1 more source
Genetic Resilience and Resistance in Alzheimer's Disease Diagnosis and Pathology
Objective Some individuals avoid Alzheimer's disease (AD) pathology as they age, or retain cognition despite substantial pathology, suggesting mechanisms of resistance or resilience to neurodegeneration. Educational attainment (EA) is associated with reduced risk of cognitive decline, although the underlying mechanisms remain unclear.
Ganna Leonenko +8 more
wiley +1 more source
High‐resolution proton detection is preserved under cryogenic dynamic nuclear polarization (DNP) by combining fast MAS, extensive deuteration and selective methyl protonation. This strategy enables proton‐detected structural studies of biomolecular solids with enhanced sensitivity under DNP conditions.
James Tolchard +16 more
wiley +2 more sources
The highest clinical trial failure rate for any disease in modern medicine: How both amyloid- and non-amyloid-targeting therapies failed to alter disease course in Alzheimer's disease. [PDF]
Guth MAS.
europepmc +1 more source

